<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38982764</PMID><DateCompleted><Year>2024</Year><Month>07</Month><Day>10</Day></DateCompleted><DateRevised><Year>2024</Year><Month>07</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1096-9071</ISSN><JournalIssue CitedMedium="Internet"><Volume>96</Volume><Issue>7</Issue><PubDate><Year>2024</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Journal of medical virology</Title><ISOAbbreviation>J Med Virol</ISOAbbreviation></Journal><ArticleTitle>First detection of multiple cases related to CV-A16 strain of B1c clade in Beijing in 2022.</ArticleTitle><Pagination><StartPage>e29796</StartPage><MedlinePgn>e29796</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/jmv.29796</ELocationID><Abstract><AbstractText>Coxsackievirus A16 (CV-A16) is a significant etiologic agent of hand, foot, and mouth disease (HFMD) and herpangina (HA), with the capacity to progress to severe complications, including encephalitis, aseptic meningitis, acute flaccid paralysis, myocarditis, and other critical conditions. Beijing's epidemiological surveillance system, established in 2008, encompasses 29 hospitals and 16 district disease control centers. From 2019 to 2021, the circulation of CV-A16 was characterized by the co-circulation of B1a and B1b clades. Multiple cases of HFMD linked to clade B1c has not been reported in Beijing until 2022. This study enrolled 400 HFMD and 493 HA cases. Employing real-time RT-PCR, 368 enterovirus-positive cases were identified, with 180 selected for sequencing. CV-A16 was detected in 18.89% (34/180) of the cases, second only to CV-A6, identified in 63.33% (114/180). Full-length VP1 gene sequences were successfully amplified and sequenced in 22 cases, revealing the presence of clades B1a, B1b, and B1c in 14, 3, and 5 cases, respectively. A cluster of five B1c clade cases occurred between June 29 and July 17, 2022, within a 7-km diameter region in Shunyi District. Phylogenetic analysis of five complete VP1 gene sequences and two full-genome sequences revealed close clustering with the 2018 Indian strain (GenBank accession: MH780757.1) within the B1c India branch, with NCBI BLAST results showing over 98% similarity. Comparative sequence analysis identified three unique amino acid variations (P3S, V25A, and I235V). The 2022 Shunyi District HFMD cases represent the first instances of spatiotemporally correlated CV-A16 B1c clade infections in Beijing, underscoring the necessity for heightened surveillance of B1c clade CV-A16 in HFMD and HA in this region.</AbstractText><CopyrightInformation>© 2024 Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Zhichao</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0009-0004-7657-9255</Identifier><AffiliationInfo><Affiliation>Institute for Infectious Disease and Endemic Disease Control, Beijing Center for Disease Prevention and Control, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Changying</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Institute for Infectious Disease and Endemic Disease Control, Beijing Center for Disease Prevention and Control, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huo</LastName><ForeName>Da</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Institute for Infectious Disease and Endemic Disease Control, Beijing Center for Disease Prevention and Control, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Yang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Institute for Infectious Disease and Endemic Disease Control, Beijing Center for Disease Prevention and Control, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feng</LastName><ForeName>Zhaomin</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Institute for Infectious Disease and Endemic Disease Control, Beijing Center for Disease Prevention and Control, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cui</LastName><ForeName>Shujuan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute for HIV/AIDS and STD Prevention and Control, Beijing Center for Disease Prevention and Control, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Dan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Institute for Infectious Disease and Endemic Disease Control, Beijing Center for Disease Prevention and Control, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ren</LastName><ForeName>Zhenyong</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Institute for Infectious Disease and Endemic Disease Control, Beijing Center for Disease Prevention and Control, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Dan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Institute for Infectious Disease and Endemic Disease Control, Beijing Center for Disease Prevention and Control, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jia</LastName><ForeName>Lei</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Institute for Infectious Disease and Endemic Disease Control, Beijing Center for Disease Prevention and Control, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dong</LastName><ForeName>Shuaibing</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-0771-5055</Identifier><AffiliationInfo><Affiliation>Institute for Infectious Disease and Endemic Disease Control, Beijing Center for Disease Prevention and Control, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dou</LastName><ForeName>Xiangfeng</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Institute for Infectious Disease and Endemic Disease Control, Beijing Center for Disease Prevention and Control, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Yulan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Institute for Infectious Disease and Endemic Disease Control, Beijing Center for Disease Prevention and Control, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Zhiyong</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0000-0003-4413-4265</Identifier><AffiliationInfo><Affiliation>Institute for Infectious Disease and Endemic Disease Control, Beijing Center for Disease Prevention and Control, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Renqing</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-0141-6812</Identifier><AffiliationInfo><Affiliation>Institute for Infectious Disease and Endemic Disease Control, Beijing Center for Disease Prevention and Control, Beijing, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>Capital's Funds for Health Improvement and Research (2020-2-1012)</Agency><Country /></Grant><Grant><GrantID>2023YFC2308705</GrantID><Agency>National Key Research and Development Program of China</Agency><Country /></Grant><Grant><GrantID>L192012</GrantID><Agency>Beijing Natural Science Foundation-Haidian District Joint Fund</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Med Virol</MedlineTA><NlmUniqueID>7705876</NlmUniqueID><ISSNLinking>0146-6615</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D036022">Capsid Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010802" MajorTopicYN="Y">Phylogeny</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000068476" MajorTopicYN="N" Type="Geographic">Beijing</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006232" MajorTopicYN="Y">Hand, Foot and Mouth Disease</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005838" MajorTopicYN="N">Genotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="N">Enterovirus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D036022" MajorTopicYN="N">Capsid Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062665" MajorTopicYN="N">Epidemiological Monitoring</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">B1c clade of CV‐A16</Keyword><Keyword MajorTopicYN="N">enterovirus</Keyword><Keyword MajorTopicYN="N">evolution</Keyword><Keyword MajorTopicYN="N">genotype</Keyword><Keyword MajorTopicYN="N">hand, foot, and mouth disease</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>6</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>3</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>7</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>7</Month><Day>10</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>7</Month><Day>10</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>7</Month><Day>10</Day><Hour>2</Hour><Minute>43</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38982764</ArticleId><ArticleId IdType="doi">10.1002/jmv.29796</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Li XW, Ni X, Qian SY, et al. Chinese guidelines for the diagnosis and treatment of hand, foot and mouth disease (2018 edition). World J Pediatr. 2018;14(5):437‐447.</Citation></Reference><Reference><Citation>Han Z, Song Y, Xiao J, et al. Genomic epidemiology of coxsackievirus A16 in mainland of China, 2000‐18. Virus Evol. 2020;6(2):veaa084.</Citation></Reference><Reference><Citation>Li J, Sun Y, Du Y, et al. Characterization of coxsackievirus A6‐ and enterovirus 71‐associated hand foot and mouth disease in Beijing, China, from 2013 to 2015. Front Microbiol. 2016;7:391.</Citation></Reference><Reference><Citation>Yu H, Li XW, Liu QB, et al. Diagnosis and treatment of herpangina: Chinese expert consensus. World J Pediatr. 2020;16(2):129‐134.</Citation></Reference><Reference><Citation>Chen X, Tan X, Li J, et al Molecular epidemiology of coxsackievirus A16: intratype and prevalent intertype recombination identified. PLoS One. 2013;8(12):e82861.</Citation></Reference><Reference><Citation>Luo D, Zhang L, Xu M, et al. Molecular epidemiological analysis of coxsackievirus A16 in 2019 in Nujiang prefecture, Yunnan province of China. Chin J Viral Dis. 2021;11(3):168‐171.</Citation></Reference><Reference><Citation>Xie J, Yang XH, Hu SQ, et al. Co‐circulation of coxsackieviruses A‐6, A‐10, and A‐16 causes hand, foot, and mouth disease in Guangzhou city, China. BMC Infect Dis. 2020;20(1):271.</Citation></Reference><Reference><Citation>Wang J, Teng Z, Cui X, et al. Epidemiological and serological surveillance of hand‐foot‐and‐mouth disease in Shanghai, China, 2012‐2016. Emerg Microbes Infect. 2018;7(1):1‐12.</Citation></Reference><Reference><Citation>Subspecialty Group of Infectious Diseases, National Center for Quality Control of Infectious D. Expert consensus on diagnosis and treatment of herpangina (version 2019). Zhonghua Er Ke Za Zhi. 2019;57(3):177‐180.</Citation></Reference><Reference><Citation>Mirand A, Schuffenecker I, Henquell C, et al. Phylogenetic evidence for a recent spread of two populations of human enterovirus 71 in European countries. J Gen Virol. 2010;91(Pt 9):2263‐2277.</Citation></Reference><Reference><Citation>He YQ, Chen L, Xu WB, et al. Emergence, circulation, and spatiotemporal phylogenetic analysis of coxsackievirus a6‐ and coxsackievirus a10‐associated hand, foot, and mouth disease infections from 2008 to 2012 in Shenzhen, China. J Clin Microbiol. 2013;51(11):3560‐3566.</Citation></Reference><Reference><Citation>Li R, Lin C, Dong S, et al. Phylogenetics and phylogeographic characteristics of coxsackievirus A16 in hand foot and mouth disease and herpangina cases collected in Beijing, China from 2019 to 2021. J Med Virol. 2023;95(8):e28991.</Citation></Reference><Reference><Citation>Li R, Lin C, Yang Y, et al. Classification of enterovirus based on pairwise alignment identity score of genome‐wide nucleotide sequences. Guoji Bing Du Xue Za Zhi. 2020;27(3):199‐204.</Citation></Reference><Reference><Citation>Crooks GE, Hon G, Chandonia JM, et al. WebLogo: a sequence logo generator. Genome Res. 2004;14(6):1188‐1190.</Citation></Reference><Reference><Citation>Lei L, Yu W, Zhang Q, et al. Etiological constitution of hand,foot and mouth disease and genetic characteristics of coxsackievirus A16 strains in Liaoning Province,2017‐2019. Guoji Bing Du Xue Za Zhi. 2020;27(3):481‐483.</Citation></Reference><Reference><Citation>Mizuta K, Abiko C, Aoki Y, et al. Molecular epidemiology of coxsackievirus A16 strains isolated from children in Yamagata, Japan between 1988 and 2011. Microbiol Immunol. 2013;57(5):400‐405.</Citation></Reference><Reference><Citation>Ganorkar NN, Fulmali PP, Tikute SS, et al. Genetic characterization of enterovirus strains identified in hand, foot and mouth disease (HFMD): emergence of B1c, C1 subgenotypes, E2 sublineage of CVA16, EV71 and CVA6 strains in India. Infect Genet Evol. 2017;54:192‐199.</Citation></Reference><Reference><Citation>Durga RC, Jagadeesh NR, Padmanabha MP, et al. Large‐scale HFMD epidemics caused by coxsackievirus A16 in Bangalore, India during 2013 and 2015. Infect Genet Evol. 2017;55:228‐235.</Citation></Reference><Reference><Citation>Li J, Liang Z, Huo D, et al. Molecular epidemiology and phylodynamic analysis of enterovirus 71 in Beijing, China, 2009‐2019. Virol J. 2023;20(1):256.</Citation></Reference><Reference><Citation>Hu YF, Jia LP, Yu FY, et al. Molecular epidemiology of coxsackievirus A16 circulating in children in Beijing, China from 2010 to 2019. World J Pediatr. 2021;17(5):508‐516.</Citation></Reference><Reference><Citation>Zhou Y, Van Tan L, Luo K, et al. Genetic variation of multiple serotypes of enteroviruses associated with hand, foot and mouth disease in Southern China. Virol Sin. 2021;36:61‐74.</Citation></Reference><Reference><Citation>Wang S, Qin L, Li Z, et al. Sequence analysis of coxsackievirus A16 in Xianyang, China from 2018 to 2022. Chin J Virol. 2024;40(2):418‐423.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>